论文部分内容阅读
目的:分析硫普罗宁治疗肝硬化的临床效果。方法:选取2013年7月-2013年12月昭觉县人民医院收治的96例肝硬化患者作为研究对象,随机将其分为对照组与观察组各48例。对照组给予常规治疗,观察组在其基础上加用硫普罗宁治疗,比较两组临床治疗肝硬化效果。结果:观察组临床总有效率为93.8%,对照组临床总有效率为81.3%,差异有统计学意义(P<0.05);观察组肝功能指标改善情况明显优于对照组,差异有统计学意义(P<0.05)。结论:硫普罗宁治疗肝硬化效果显著,患者肝功能得到明显改善。
Objective: To analyze the clinical effect of tiopronin in the treatment of liver cirrhosis. Methods: A total of 96 patients with cirrhosis admitted in Zhaojue County People’s Hospital from July 2013 to December 2013 were randomly divided into control group and observation group of 48 cases. The control group was given routine treatment. The observation group was treated with tiopronin on the basis of the above, and the clinical effects of the two groups on the treatment of liver cirrhosis were compared. Results: The total clinical effective rate was 93.8% in the observation group and 81.3% in the control group, the difference was statistically significant (P <0.05). The improvement of liver function indexes in the observation group was obviously better than that in the control group Significance (P <0.05). Conclusion: The effect of tiopronin in the treatment of liver cirrhosis is remarkable, and the liver function of patients is obviously improved.